Philadelphia, Pennsylvania 19107

  • Shoulder Pain

Purpose:

The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even for common procedures. Patients undergoing arthroscopic labrum repair of the shoulder were found to have an average of 20 pills left over after surgery. Many strategies have been developed to tackle overprescribing and have found success, including no opioid protocols for carpal tunnel release. The purpose of this study is to examine if meloxicam alone provides similar patient reported outcomes to opioids following arthroscopic labrum repair of the shoulder.


Criteria:

Inclusion Criteria: - Age ≥ 18 - Scheduled for arthroscopic labrum repair of the shoulder Exclusion Criteria: - History of opioid, acetaminophen, NSAID or local anesthetic allergy or intolerance, or contraindications to these medications. - Currently on long-term preoperative narcotics - Scheduled for revision arthroscopic repairs of the shoulder - Unable/unwilling to consent for enrollment - Unable to complete postoperative surveys - History of chronic pain syndromes (fibromyalgia, chronic diffuse MSK pain, etc) - Patients under the age of 18 - Pregnant or breastfeeding women - Scheduled for concurrent procedures


NCT ID:

NCT04725357


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 21, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.